FIRST ON FOX: The state of Kansas has filed a lawsuit against pharmaceutical company Pfizer, Inc. for alleged consumer ...

In another sign of the challenges facing gene therapy developers, Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable.

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.

U.S. President Donald Trump gestures next to a new flagpole with the U.S. flag after disembarking Marine One upon arrival at the White House in Washington, D.C., U.S., June 21, 2025. REUTERS/Kevin ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.